SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $471K invested in Sonnet BioTherapeutics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$251K
2
+$80K

Top Sellers

1
-$26K
2
-$19K
3
-$16K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$15K
5
VF
Virtu Financial
New York
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$251K
2
$80K
3
$35K
4
$27K
5
$21K
6
$20K
7
$19K
8
$9K
9
$6K
10
$3K
11
–
12
–
13
–
14
–